KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Net Income (2017 - 2025)

Twist Bioscience (TWST) has disclosed Net Income for 6 consecutive years, with -$46.3 million as the latest value for Q3 2023.

  • On a quarterly basis, Net Income rose 9.41% to -$46.3 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$204.7 million, a 6.06% increase, with the full-year FY2025 number at -$77.7 million, up 62.8% from a year prior.
  • Net Income was -$46.3 million for Q3 2023 at Twist Bioscience, up from -$57.4 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$24.3 million in Q3 2020 to a low of -$60.7 million in Q1 2022.
  • A 5-year average of -$42.1 million and a median of -$41.3 million in 2021 define the central range for Net Income.
  • Peak YoY movement for Net Income: crashed 145.76% in 2019, then surged 40.87% in 2020.
  • Twist Bioscience's Net Income stood at -$55.6 million in 2019, then soared by 40.87% to -$32.9 million in 2020, then tumbled by 38.49% to -$45.6 million in 2021, then increased by 8.21% to -$41.8 million in 2022, then decreased by 10.73% to -$46.3 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Net Income are -$46.3 million (Q3 2023), -$57.4 million (Q2 2023), and -$59.2 million (Q1 2023).